Abstract:
Objective To investigate the role and clinical significance of the phosphatidylinositol-4, 5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) gene in the occurrence and development of cervical squamous cell carcinoma(CSCC)and its relationship with clinicopathological features.
Methods A total of 112 CSCC tissue samples with complete clinicopathologicaldata and confirmed diagnoses collected between January 2013 and May 2019 at the Affiliated Hospital of Guizhou Medical University were analyzed, with adjacent tissues serving as controls. The mutations of the PIK3CA gene were detected by next-generation sequencing (NGS), and the protein expression was detected by immunohistochemistry (IHC). Gene ontology (GO) and Kyoto encyclopedia of genes and genomes (KEGG) enrichment analyses were performed through the Cancer Genome Atlas (TCGA) database. Molecular dynamics simulations were used to study the effects of E542K and E545K mutations on the structure, function, and stability of the PIK3CA protein.
Results Among the 112 CSCC tissue samples, the mutation frequency of PIK3CA was 27.68% (31/112), with E545K and E542K identified as hotspot mutations, which occurred at significantly higher frequencies than those in adjacent tissues. IHC detection found that the expression of PIK3CA protein in CSCC was significantly stronger than that in adjacent tissues, and the difference was statistically significant (χ2=28.52, P<0.0001). The expression level of PIK3CA protein was positively correlated with Ki-67 (χ2= 5.684, P=0.0171), and its expression levels were significantly higher in the E545K and E542K mutant groups than in the wild-type group (P<0.01). A significant association was also observed between PIK3CA expression and HPV16 infection (χ2=9.584, P=0.002). Molecular dynamics simulations found that E545K and E542K mutations induced structural, functional, and stability alterations in the PIK3CA protein complex (p110α-p85α).
Conclusions The mutation frequency of the hot spot mutation sites E545K and E542K of PIK3CA gene in CSCC is relatively high. PIK3CA mutations increase protein expression and promote the proliferation and invasion of CSCC cells in collaboration with HPV infection. The underlying mechanism is that E542K and E545K mutations disrupt the stability of the interactions between key subunits in the PIK3CA protein complex, leading to dysregulation of the PI3K signaling pathway and promoting tumor cell proliferation, thereby causing the occurrence and development of CSCC. This suggests that PIK3CA may serve as a potential biomarker or molecular target for the diagnosis and treatment of CSCC.